跳至主要内容
临床试验/ISRCTN85912420
ISRCTN85912420已完成未知

Placental growth fActor Repeat sampling for Reduction of adverse perinatal Outcomes in women with suspecTed pre-eclampsia

King's College London0 个研究点目标入组 1,252 人开始时间: 2019年11月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
1,252

研究概览

简要总结

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36056408/ (added 05/09/2022) 2024 Results article in https://doi.org/10.1016/s0140-6736(23)02357-7 (added 12/02/2024) 2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38708607/ (added 07/05/2024)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Women aged 18 years or more between 22+0 and 35+6 weeks’ gestation with clinical suspicion of pre-eclampsia
  • 2. Viable singleton pregnancy
  • 3. Able to give written informed consent

排除标准

  • Confirmed preterm pre-eclampsia at presentation

研究者

相似试验